Mark Klausner is an Independent Director of the Company. He is the co-founder and managing partner of Westwicke, an ICR Company, a capital markets advisory and investor relations firm focused on the healthcare industry. Prior to co-founding Westwicke in 2006, Mr. Klausner was a managing director in the equity capital markets group at Wachovia Corporation (now Wells Fargo Corporation) from 2004 to 2006. Prior to this, from 1991 to 2004, he worked in investment banking, equity capital markets and commercial banking positions at firms including Deutsche Bank (and predecessor firms Bankers Trust and Alex. Brown & Sons), Merrill Lynch (now Bank of America Merrill Lynch) and Citibank. Mr. Klausner earned his bachelor’s degree in Economics and Computer Science from Colgate University and his Master of Business Administration from the University of Virginia Darden School of Business.
As the Independent Director of Oxford Immunotec Global PLC, the total compensation of Mark Klausner at Oxford Immunotec Global PLC is $90,943. There are 8 executives at Oxford Immunotec Global PLC getting paid more, with Peter Wrighton-Smith having the highest compensation of $2,151,490.
Mark Klausner is 54, he's been the Independent Director of Oxford Immunotec Global PLC since 2018. There are 6 older and 4 younger executives at Oxford Immunotec Global PLC. The oldest executive at Oxford Immunotec Global PLC is Richard Sandberg, 77, who is the Independent Director.
Mark's mailing address filed with the SEC is C/O OXFORD IMMUNOTEC GLOBAL PLC, 94C INNOVATION DRIVE, ABINGDON, OXFORDSHIRE, X0, OX14 4RZ.
Over the last 11 years, insiders at Oxford Immunotec Global PLC have traded over $13,598,906 worth of Oxford Immunotec Global PLC stock and bought 47,600 units worth $549,576 . The most active insiders traders include James R Tobin, Peter Wrighton Smith y Ronald Asbury Andrews. On average, Oxford Immunotec Global PLC executives and independent directors trade stock every 36 days with the average trade being worth of $536,006. The most recent stock trade was executed by Patrick J Balthrop on 20 May 2020, trading 4,000 units of OXFD stock currently worth $49,920.
Oxford Immunotec Global PLC executives and other stock owners filed with the SEC include: